New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For NSRGY;PFE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 21, 2015
10:01 EDTPFEPfizer receives FDA breakthrough therapy designation for Xalkori
Subscribe for More Information
08:18 EDTPFEPain Therapeutics resumes responsibility for Remoxy
Subscribe for More Information
08:06 EDTPFEPfizer says Phase 3 inotuzumab ozogamicin study met first primary endpoint
Subscribe for More Information
April 20, 2015
08:02 EDTPFEMerck KGaA, Pfizer initiate Phase III study with Avelumab
Subscribe for More Information
06:05 EDTPFEProvectus receives notice of allowance for PV-10 combined with other drugs
Subscribe for More Information
April 17, 2015
05:32 EDTNSRGYNestle confirms FY15 organic growth outlook of around 5%
Subscribe for More Information
05:29 EDTNSRGYNestle reports three-month organic growth of 4.4%, 1.9% real internal growth
Subscribe for More Information
April 16, 2015
11:44 EDTNSRGYNestle continues to streamline its business as competition heats up, WSJ says
Subscribe for More Information
April 15, 2015
08:04 EDTPFEPfizer: PALOMA-3 trial for IBRANCE met primary endpoint, trial stopped early
Subscribe for More Information
April 14, 2015
06:51 EDTNSRGYNestle in advanced talks to sell Davigel unit to Brakes Group, Reuters reports
Nestle is in advanced discussions for the sale of its Davigel frozen food group to Bain Capital's Brakes Group, Reuters reports, citing a source. A second source says the sale of the deal, which is being handled by Credit Suisse, could raise EUR200M-EUR300M. Reference Link
April 13, 2015
15:12 EDTPFEMylan enters settlement, license agreement with Pfizer regarding Viagra
Mylan (MYL) announced that its subsidiaries Mylan Inc. and Mylan Pharmaceuticals have entered into a settlement and license agreement with Pfizer (PFE), Pfizer Limited and Pfizer Ireland Pharmaceuticals to settle patent litigation relating to Mylan's Abbreviated New Drug Application filed with the U.S. FDA for Sildenafil Citrate Tablets 25 mg, 50 mg, and 100 mg. This product is the generic version of Viagra, which is indicated to treat erectile dysfunction. Under the terms of the agreement, Mylan will be able to launch its ANDA products pursuant to a royalty-bearing license as early as December 11, 2017, or sooner under certain conditions, subject to FDA approval. All other terms and conditions of the settlement and license agreement are confidential, and the agreement itself is subject to review by the U.S. Department of Justice and the Federal Trade Commission. For the 12 months ending Dec. 31, 2014, Viagra had U.S. sales of approximately $1.3B, according to IMS Health.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use